S. Corsetti

Multicenter phase II trial of first-line docetaxel/gemcitabine in advanced breast cancer pretreated with adjuvant anthracyclines.

G. Colucci, V. Lorusso, P. Foggi, 2009, Anticancer research.

An Exceptional Response to Dostarlimab in Mismatch Repair Deficient, Microsatellite Instability-High and Platinum Refractory Endometrial Cancer

M. Nicoloso, F. Puglisi, A. Viel, 2022, Current oncology.

Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial.

M. Nicoloso, S. Pignata, G. de Matteis, 2023, The Lancet. Oncology.

Mast cells and cancer: a review of literature.

S. Calvieri, G. Paolino, D. Didona, 2019, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

M. Pirmohamed, A. Cambon-Thomsen, Yitian Zhou, 2023, The Lancet.

A Phase II Trial of Docetaxel and Vinorelbine in Patients with Advanced Breast Cancer Previously Treated with Anthracyclines

M. Mottolese, P. Foggi, D. Giannarelli, 2008, Oncology.

Optimal sequence of anthracyclines and taxanes as adjuvant breast cancer treatment.

P. Foggi, P. Vici, D. Sergi, 2008, Clinica Terapeutica.

Clinical impact of body mass index on palbociclib treatment outcomes and effect on exposure.

M. Montico, F. Puglisi, M. Baraldo, 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring

M. Montico, G. Toffoli, R. Roncato, 2023, Pharmaceutics.

Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancer.

G. Toffoli, R. Roncato, E. De Mattia, 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Docetaxel in the adjuvant therapy of HER-2 positive breast cancer patients.

M. Mottolese, P. Foggi, P. Perri, 2008, La Clinica terapeutica.

Therapeutic Monitoring of Palbociclib, Ribociclib, Abemaciclib, M2, M20, and Letrozole in Human Plasma: A Novel LC-MS/MS Method

R. Roncato, S. Corsetti, S. Gagno, 2024, Therapeutic drug monitoring.